Late-Breaking Science oral abstracts for Wednesday
Four oral abstracts are scheduled for 2 p.m. today.
2-3 p.m. | Wednesday, Feb. 5 | Room 151
Volume of Brain Saved in Patients With a Medium Distal Vessel Occlusion Stroke Treated With Endovascular Therapy Plus Best Medical Treatment Versus Best Medical Treatment Alone: A Subanalysis of the DISTAL Trial
The SYCAMORE Study Results: First Randomized, Placebo-Controlled Phase 2 Trial in Symptomatic Cerebral Cavernous Malformation (CCM) Evaluating REC-994
Efficacy and Safety of Minocycline in Patients With Acute Ischemic Stroke (EMPHASIS): A Randomized Control Trial
Targeting Cerebral Amyloid Angiopathy at its Source: An Amyloid Beta Precursor Protein-Targeted siRNA Reduced Vascular Amyloid Beta and Hemorrhage in Rodent Models
See Online Program Planner for more information.
